| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.722 | 31.896 | - | 223.907 | 88.243 | - | - | - | - | - |
| Total Income - EUR | 43.166 | 35.211 | - | 261.854 | 88.993 | - | - | - | - | - |
| Total Expenses - EUR | 36.556 | 32.761 | - | 249.881 | 47.968 | - | - | - | - | - |
| Gross Profit/Loss - EUR | 6.610 | 2.449 | - | 11.972 | 41.025 | - | - | - | - | - |
| Net Profit/Loss - EUR | 5.315 | 1.418 | - | 9.444 | 40.001 | - | - | - | - | - |
| Employees | 0 | 1 | - | 1 | 1 | - | - | - | - | - |
Check the financial reports for the company - Rmv E-Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 926 | 917 | - | 884 | 867 | - | - | - | - | - |
| Current Assets | 15.468 | 24.391 | - | 40.951 | 97.260 | - | - | - | - | - |
| Inventories | 8.096 | 20.650 | - | 17.877 | 76.085 | - | - | - | - | - |
| Receivables | 642 | 1.337 | - | 20.598 | 21.009 | - | - | - | - | - |
| Cash | 6.730 | 2.403 | - | 2.476 | 166 | - | - | - | - | - |
| Shareholders Funds | 9.230 | 10.554 | - | 24.740 | 64.262 | - | - | - | - | - |
| Social Capital | 47 | 47 | - | 45 | 44 | - | - | - | - | - |
| Debts | 7.163 | 14.753 | - | 17.101 | 33.872 | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Rmv E-Pharm Srl